Rigel Pharmaceuticals, Inc. (RIGL)
46.48
-0.38
(-0.81%)
USD |
NASDAQ |
Aug 28, 16:00
46.52
+0.04
(+0.09%)
After-Hours: 20:00
Rigel Pharmaceuticals Free Cash Flow : 9.042M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 9.042M |
| March 31, 2026 | 79.27M |
| December 31, 2025 | 75.66M |
| September 30, 2025 | 68.14M |
| June 30, 2025 | 65.79M |
| March 31, 2025 | 35.33M |
| December 31, 2024 | 31.08M |
| September 30, 2024 | 10.36M |
| June 30, 2024 | -12.67M |
| March 31, 2024 | -6.82M |
| December 31, 2023 | -20.74M |
| September 30, 2023 | -36.48M |
| June 30, 2023 | -48.62M |
| March 31, 2023 | -67.42M |
| December 31, 2022 | -74.21M |
| September 30, 2022 | -71.29M |
| June 30, 2022 | -68.27M |
| March 31, 2022 | -0.584M |
| December 31, 2021 | 5.251M |
| September 30, 2021 | 8.24M |
| June 30, 2021 | -0.97M |
| March 31, 2021 | -69.77M |
| December 31, 2020 | -53.45M |
| September 30, 2020 | -47.63M |
| June 30, 2020 | -42.95M |
| Date | Value |
|---|---|
| March 31, 2020 | -45.72M |
| December 31, 2019 | -42.96M |
| September 30, 2019 | -21.13M |
| June 30, 2019 | -26.38M |
| March 31, 2019 | -37.29M |
| December 31, 2018 | -59.93M |
| September 30, 2018 | -91.28M |
| June 30, 2018 | -88.70M |
| March 31, 2018 | -80.51M |
| December 31, 2017 | -77.72M |
| September 30, 2017 | -70.42M |
| June 30, 2017 | -75.58M |
| March 31, 2017 | -74.76M |
| December 31, 2016 | -76.69M |
| September 30, 2016 | -78.15M |
| June 30, 2016 | -65.10M |
| March 31, 2016 | -64.66M |
| December 31, 2015 | -23.96M |
| September 30, 2015 | -25.23M |
| June 30, 2015 | -33.80M |
| March 31, 2015 | -35.60M |
| December 31, 2014 | -70.17M |
| September 30, 2014 | -74.02M |
| June 30, 2014 | -76.55M |
| March 31, 2014 | -78.10M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Ironwood Pharmaceuticals, Inc. | 185.55M |
| Cytokinetics, Inc. | -580.72M |
| Perspective Therapeutics, Inc. | -121.38M |
| Capricor Therapeutics, Inc. | -129.78M |
| ACADIA Pharmaceuticals, Inc. | 145.62M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 30.65M |
| Cash from Investing (Quarterly) | 17.45M |
| Cash from Financing (Quarterly) | -11.70M |
| Free Cash Flow Per Share (Quarterly) | -2.028 |
| Free Cash Flow to Equity (Quarterly) | -33.92M |
| Free Cash Flow to Firm (Quarterly) | -39.28M |
| Free Cash Flow Yield | 1.00% |